Alberti A, Corbella S, Tashcnieri S, et al. Fungal species in endodontic infections: a systematic review and meta-analysis. PLOS One 2021 (published online Jul 22)
Borman AM, Fountain H, Guy R, et al. Increased mortality in COVID-19 patients with fungal co- and secondary infections admitted to intensive care or high dependency units in NHS hospitals in England. J Infect 2022 (published online Jan 4)
Brennan-Krohn T, Friar L, Ditelberg S, et al. Evaluation of the synergistic activity of antibacterial and antifungal drugs against Candida auris using an inkjet printer-assisted method. Antimicrob Agents Chemother 2021 (published online Jul 12)
Gangneux JP, Dannaoui E, Fekkar A, et al. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Lancet Respir Med 2021 (published online Nov 26)
Gold JAW, Ahmad FB, Cisewski JA, et al. Increased deaths from fungal infections during the COVID-19 pandemic—National Vital Statistics System, United States, January 2020–December 2021. Clin Infect Dis 2022 (published online Jun 19)
Gold JAW, Revis A, Thomas S, et al. Clinical characteristics, healthcare utilization, and outcomes among patients in a pilot surveillance system for invasive mold disease—Georgia, United States, 2017–2019. Open Forum Infect Dis 2022 (published online Apr 21)
Hanson BM, Dinh AQ, Tran TT, et al. Candida auris invasive infections during a COVID-19 case surge. Antimicrob Agents Chemother 2021 (published online Aug 2)
Jones M, Micallef C, Tyler N, et al. The impact of an antifungal stewardship team on voriconazole therapeutic drug monitoring in a UK tertiary hospital. J Infect 2021 (published online Jul 27)
Lyman M, Forsberg K, Reuben J, et al. Transmission of pan-resistant and echinocandin-resistant Candida auris in health care facilities―Texas and the District of Columbia, January–April 2021. MMWR (Notes from the field) 2021 Jul 23;70(29):1022-3
Rannikko J, Holmberg V, Karppelin M, et al. Fungemia and other fungal infections associated with use of Saccharomyces boulardii probiotic supplements. Emerg Infect Dis 2021 Aug;27(8)
Prattes J, Wauters J, Giacobbe DR, et al. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients–a multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect 2021 (published online Aug 25)
Zhang Z, Cao U, Li Y, et al. Risk factors and biofilm formation analyses of hospital-acquired infection of Candida pelliculosa in a neonatal intensive care unit. BMC Med 2021 Jun 29;21:1247
